Robatumumab (Synonyms: Sch 717454; 19D12) |
| Catalog No.GC69825 |
Robatumumab (Sch 717454) est un anticorps anti-récepteur humain IGF-1R (récepteur de facteur de croissance insulinique de type 1). Robatumumab a une activité antitumorale et une activité anti-proliférative des cellules cancéreuses. Robatumumab peut être utilisé dans la recherche sur l'ostéosarcome et le sarcome d'Ewing.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 934235-44-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Robatumumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Robatumumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *